Studio sull'angiogenesi nei tumori colici Dukes'B

Clinica Terapeutica

Volumn 150, Issue 5, 1999, Pages 331-337

  Pantalone, Desiree ^a   Ziche, M ^b   Messerini, L ^b   Pazzagli, M ^b   Morbidelli, L ^b   Parenti, A ^b   Donnini, S ^b   Palomba, A R ^b   Tricarico, C ^b   Paolucci, R ^b   Taruffi, F ^b   Andreoli, F ^b  

^a Policlinico di Careggi   (Italy)

^b NONE

Author keywords

Angiogenesis; Colonic cancer; VEGF (vascular endothelial growth factor)

Indexed keywords

ENDOTHELIAL CELL GROWTH FACTOR; ISOPROTEIN; LYMPHOKINE; TUMOR MARKER; VASCULOTROPIN; VASCULOTROPIN A;

AGED; ARTICLE; CANCER STAGING; CHEMISTRY; COLON; COLON TUMOR; FEMALE; HUMAN; MALE; METASTASIS; MIDDLE AGED; MORTALITY; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PROGNOSIS; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AGED; COLON; COLONIC NEOPLASMS; ENDOTHELIAL GROWTH FACTORS; FEMALE; HUMANS; LYMPHOKINES; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; PROSPECTIVE STUDIES; PROTEIN ISOFORMS; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0033182208     PISSN: 00099074     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (69)

1. Folkman J: Tumour angiogenesis: diagnostic and therapeutic clinical applications. In: Salomon S.E. Adjuvant therapy of cancer VII (ed), JB Lippincott company, 1993, pp. 27-33
2. Bussolino F, Albini A, Camussi G, et al.: Role of soluble mediators in angiogenesis. Eur J Cancer 32A(14): 2401-2412, 1996
3. Tomlinson IPM and Bodmer WF :Modelling the consequences of interactions between tumour cells. Br J Cancer 75(2):157-180, 1997
4. Stetler-Stevenson WG: Dynamics of matrix turnover during pathologic remodelling of extracellular matrix. Am J Pathol 148: 1343-1350, 1996
5. Polverini PJ: How the extracellular matrix and macrophages contribute to angiogenesis-dependent disease. Eur J Cancer 32A(14): 2430-2437,1996
6. Sage HE, Bornstein P: Extracellular proteins that modulate cell-matrix interactions. J Biol Chem 266: 14831-12834, 1991
7. Brooks PC, Stromblad S, Sanders LC, et al.: Localization of matrix metallo-proteinase MMP-2 to the surface of invasive cells by ineraction with integrin anb3. Cell 85: 683-693, 1996
8. Koch AE, Halloran MN, Haskell CJ, Shah MR, Polverini PJ: Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1. Nature 376: 517-519,1995
9. Sunderkotter C, Steinbrink K, Goebeler M, et al.: Macrophages and angiogenesis. J Leukoc Biol 55: 410-22, 1994
10. Ziche M, Morbidelli L, Masini E, et al.: Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P J Clin Invest 94: 2036-2044, 1994
11. Ziche M, Morbidelli L, Choudhuri R, et al.: Nitric Oxide Synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis. J Clin Invest 99: 2625-2634,1997
12. Ferrara N: Vascular Endothelial Growth Factor. Eur J Cancer 32A(14): 2413-2422,1996
13. Ferrara N: The role of vascular endothelial growth factor in pathological angiogenesis. Breast Cancer Res Treat 36:127-137, 1995
14. Marme D: Tumor angiogenesis:the pivotal role of vascular endothelial growth factor. World J Urol 14: 166-174,1996
15. Rifkin DB, Moscatelli D: Recent developments in the cell biology of basic fibroblast growth factor. J Cell Biol 109:1-6, 1989
16. Gualanris A, Runati M, Belleri M, et al.: Basic fibroblast growth factor overexpression in mouse endothelial cells: an autocrine model of angiogenesis and angioproliferative disease. Cell Growth Diff 147-160, 1996
17. Jakson CL, Reidy MA: Basic fibroblast growth factor: its role in the control of smooth muscle cell migration. Am M J Pathol 143:1024-1031, 1993
18. Gross JL, Herblin WF, Dvorak BA, et al.: Effects of modulation of basic fibroblast growth factor on tumor growth in vivo. J Natl Cancer Inst 85:121-131, 1993
19. Takahashi Y, Bucana CD, Liu W, et al.: Platelet derived endothelial cell growth factor in human colon cancer angiogenesis: role of infiltrating cells. J Natl Cancer Inst 88:1146-1151, 1996
20. Brooks PC: Role of integrins in angiogenesis. Eur J Cancer 32A (14): 2423-2429, 1996
21. Hynes RO: Integrins. Versatility, modulation and signaling in cell adhesion.Cell 69: 11-25, 1992
22. Rak J, Filmus J and Kerbel RS: Reciprocal paracrine interactions between tumour cells and endothelial cells: "Angiogenesis Progression" Hypothesis. Eur J Cancer 32A(14): 2438-2450, 1996
23. Folkmann J, D'Amore PA: Blood vessel formation: what is it molecular basis. Cell 87: 1153-1155, 1996
24. Fearon ER, Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 340-357, 1990
25. Lynch HT, Lynch JF: Genetics of colonie cancer. Digestion 59: 481-492, 1998
26. Ilyas M, Straub J, Tomlinson IPM, et al.: Genetic pathways in colorectal and other cancers. Eur J Surg 35(3): 335-351, 1999
27. Toi M, Taniguchi T, Yamamoto Y, et al.: Clinical significance of the determination of angiogenic factors. Eur J Cancer 32A(14): 2513-2519,1996
28. Takahashi Y, Tucker SL, Kitadai Y, et al: Vessel counts and expression of vascular endothelial growth factor as prognostic factors in node-negative colon cancer. Arch Surg 132:541-546,1997
29. Ellis CJ, Bennet ST, Chambers AF, et al.: Tumor angiogenesis predicts recurrence in invasive colorectal cancer when controlled for Dukes staging. Am J Surg Pathol 20(10): 1260-1265, 1996
30. Frank R, Saclarides TJ, Leurgans S, et al.: Tumor angiogenesis as a predictor of recurrence and survival in patients with node negative colon cancer. Ann Surg: 222(6): 695-699,1995
31. Kang SM, Maeda K, Onoda N et al: Combined analysis of p53 and vascular endothelial growth factor expression in colorectal carcinoma for determination of tumour vascularity and liver metastasis. Int J Cancer 74, 502-507, 1997
32. Saclarides TJ: Angiogenesis in colorectal cancer. Surg Clin North Am 1: 253-260, 1997
33. Vermeulen PB, Roland L, Mertens I, et al.: Correlation of intratumoral microvessel density and p53 protein overexpression in human colorectal adenocarcinoma. Microvascular research 51: 164-174, 1996
34. Takahshi Y, Bucana CD, Clearly KR, et al.: P53 vessel count, and vascular endothelial growth factor expression in human colon cancer. Int J Cancer 79: 34-38, 1998
35. Mooteri MD, Rubin D, Leurgans S: Tumor angiogenesis in primary and metastatic colorectal cancer. Dis Colon Rectum 39(10): 1073-1080, 1996
36. Fidler IJ: Molecular biology of cancer: invasion and metastasis. In: De Vita VT, Hellman S Jr, Rosemberg SA Editors. Cancer: Principles and practice of oncology (Fifth ed). Philadelphia, Lippincott-Raven Publishers, 1997
37. Vermeulen PB, Gasparini G, Fox SB, et al.: Quantification of angiogenesis in solid human tumours: an international consensus on methodology and criteria of evaluation. Eur J Cancer 32A(14): 2474-2484, 1996
38. Barbareschi M, et al.: Microvessel density quantification in breast carcinomas: assessment by manual vs. a computer-assisted image analysis system. Appl Immunoistochem 3: 74-84, 1995
39. Kaplan E, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Ass 58: 457-481, 1958
40. Mattheus DE, Farewell VT: Statistica Medica: Log-rank test o test di Mantel-Haenzsel per il confronto di sopravvivenze. Ed Minerva Medica, 1988
41. Bresalier RS: The biology of colorectal cancer metastasis. Gastroenterol Clin North Am 25(4): 805-820, 1996
42. Weidner N: Tumoural vascularity as a prognostic factor in cancer patients: the evidence continues to grow. J Pathol 184: 119-122, 1998
43. Norton JA: Tumor angiogenesis, Editorial. Ann Surg 222(6): 693-694, 1995
44. Meyer T and Hart IR: Mechanism of tumour metastasis. Eur J Cancer 34(2): 214-221,1998
45. Ellis LM and Fidler IJ: Angiogenesis and metastasis. Eur J Cancer 32A(14): 2451-2460, 1996
46. Tanigawa N, Amaya H, Matsumara M, et al.: Tumour angiogenesis and mode of metastasis in patients with colorectal cancer. Cancer Res 57(15): 1043-1046, 1997
47. Tomisaki S, Ohno S, Ichiyoshi Y, et al.: Microvessel quantification and its possible relation with liver metastasis in colorectal cancer. Cancer 77: 1722-8, 1996
48. Bicknell R and Harris AL: Anti-cancer strategies involving the vasculature-vascular targeting and the inhibition of angiogenesis. Seminar Cancer Biol 3: 399-407, 1992
49. Zimmerman MA, Craig HS, Harken AH: Surgical implications of therapeutic angiogenesis. Surgery 125(3): 243-249,1999
50. Winlaw DS: Angiogenesis in the pathobiology and treatment of vascular and malignant disease. Ann Thorac Surg 64: 1204-1211, 1997
51. Mc Namara DA, Harmey JH, Walsh TN, et al.: Significance of angiogenesis in cancer therapy. Br J Surg 85, 1044-1055, 1998
52. O'Reilly MS, Holmgreen L, Shing Y: Angiostatin: a novel angiogenesis inhibitor hat mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79, 315-328, 1994
53. Fidler IJ and Ellis LM: The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell 79: 185-188, 1994
54. Konno H, Tanaka T, Kanai T, et al.: Efficacy of an angiogenesis inhibitor, TPN-470, in xenotransplanted human colorectal cancer with high metastatic potential. Cancer 77: 1736-1740, 1996
55. Folkman J: New perspective in clinical oncology from angiogenesis research. Eur J Cancer 32A(14): 2534-2539,1996
56. Fontanini G, Del Mastro L and Bevilacqua G :Determination of angiogenesis in human neoplasm: current prognostic and therapeutic implications. Forum Trends Exp. and Clin. Med 8: 1228-142, 1998
57. Hanahan DA: A flankin attack on cancer. Nat Med 4:13-14, 1998
58. Asahara T, Bauters C, Zheng LP et al: Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo. Circulation 92: 365-371, 1995 (Suppl 2)
59. Yamamoto S, Konishi I, Mandai M, et al.: Expression of vacular endothelial growth factor (VEGF) in epithelial ovarian neoplasm: correlation with clinicopathology and patient survival, and analysis of serum VEGF levels. Br J Cancer 75(9): 1221-1227,1997
60. Angiolillo AI, Kanegane H, Sgadai C, et al.: Interleukin-15 promotes angiogenesis in vivo. Biochem. Biophys. Res Commun 233: 231-237, 1997
61. Donovan D, Harmey JH, Toomey D, et al.: Transforming growth factor beta-1 regulation of vascular endothelial growth factor production by breast cancer cells. Ann Surg Oncol 4: 621-7, 1997
62. Gleave ME, Hsieh JT, Wu HC, et al: Epidermal growth factor receptor-mediated autocrine and paracrine stimulation of human transitional cell carcinoma. Cancer Res 53: 5300-5307,1993
63. Goldman CK, Kim J, Wong WL, et al.: Epidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells: a model of glioblastoma multiforme pathophysiology. Mol Biol Cell 4: 121-33, 1993
64. Hanahan D, Christofori G, Naik P et al.: Transgenic mouse models of tumour angiogenesis: the angiogenic switch, its molecular controls, and propects for preclinical therapeutic models. Eur J Cancer 32A(14): 2386-2393,1996
65. Moghaddam A, Zhang HT, Fan T, et al: Thymidine phosphorylase is angiogenic and promotes tumor growth. Proc Natl Acad Sci USA 92: 998-1002, 1995
66. Hanahan D, Folkman J: Patterns and emerging mechanism of the angiogenic switch during tumorigenesis. Cell 86: 353-64,1996
67. Namiki A, Brogi E, Kearney M, et al: Hypoxia induces vascular endothelial growth factor in cultured human endothelial cells. J Biol Chem 270(31): 189-95, 1995
68. Brogi E, Shatterman G, Wu T, et al.: Hypoxia-induced paracrine regulation of vascular endothelial growth factor receptor expression. J Clin Invest 97: 469-76, 1996
69. Harmey J, Dimitriadis E, Redmond HP, et al.: Macrophage production of vascular endothelial growth factor (VEGF) is differentially regulated by hypoxia and transforming growth factor beta1. Ann Surg Oncol 5: 271-8, 1998